NCT03742440View on ClinicalTrials.gov

GrafixPL PRIME Evaluation Case Study

PHASE4CompletedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

November 20, 2018

Primary Completion Date

March 1, 2020

Study Completion Date

March 1, 2020

Conditions

Diabetic Foot Ulcer

Interventions

BIOLOGICAL

GrafixPL PRIME

GrafixPL PRIME

Trial Locations (1)

75390

UT Southwestern Medical Center at Dallas, Dallas

Sponsors

Collaborators (1)

Osiris Therapeutics

All Listed Sponsors

collaborator

Osiris Therapeutics

INDUSTRY

lead

University of Texas Southwestern Medical Center

OTHER